Polpharma
Generieke geneesmiddelen, API's, biologische geneesmiddelen en vrij verkrijgbare geneesmiddelen.
Polpharma produceert generieke geneesmiddelen, API's, biologische geneesmiddelen en zelfzorggeneesmiddelen vanuit zijn Starogard Gdanski-activiteiten. Het bedrijf levert aan apotheekkanalen, ziekenhuisinkopers, distributeurs in de gezondheidszorg of exportklanten op zijn beursgenoteerde primaire markten.
- Type
- manufacturer (our classification of the record, not a statement by the company)
- Role
- Manufacturer
- Location
- Starogard Gdanski, Poland
- Founded
- 1935
- Website
- polpharma.com
- Categories
- Medische en gezondheidszorgbenodigdheden, Supplementen & Welzijn
- Markets
- Polen, Duitsland, Tsjechië, Kazachstan
What is established and what is not
No facet of this company has been investigated yet. The facts below are collected records, not an assessment: nothing here confirms manufacturing, ownership or trading status beyond what each record literally says.
Verified facts
- sanctions-clear (green), checked 2026-08-12 - screened by name only: no legal entity is established for this record, so this is not a clearance OpenSanctions
- debarment-clear (green), checked 2026-08-12 - screened by name only: no legal entity is established for this record, so this is not a clearance OpenSanctions
- domain-registered (green), checked 2026-08-12 Domain registry record
Claimed certifications, not confirmed by us
- Good Manufacturing Practice
- ISO 9001, Quality Management IAF CertSearch
Import rules for these goods
- Medical devices sold in the EU must carry CE marking under the Medical Device Regulation (EU) 2017/745, with a conformity assessment matched to the device risk class. European Commission (MDR)
- For the US market, the maker must have an FDA device establishment registration and product listing; most instruments also need 510(k) premarket clearance. US FDA (devices)